These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1024274)

  • 21. [Clinical study on ischemic heart disease--study into the long-term prognosis of ischemic heart disease in special clinic of circulatory diseases].
    Kasahara Y
    Zasshi Tokyo Ika Daigaku; 1970 Mar; 28(2):327-41. PubMed ID: 5535781
    [No Abstract]   [Full Text] [Related]  

  • 22. Intra-aortic balloon counterpulsation: rationale, application and results.
    Amsterdam EA; Awan NA; Lee G; Low R; Joye JA; Foerster J; Rendig S; Mason DT
    Cardiovasc Clin; 1981; 11(3):79-96. PubMed ID: 7011557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Regional circulatory changes in heart failure as affected by intravenous nitroglycerin administration].
    Elizarova NA; Bitar S; Samiev UB
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(2):75-9. PubMed ID: 6814465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapy of coronary insufficiency with carbochromen].
    Kipsidze NN; Capidze GJ
    Arzneimittelforschung; 1970 Mar; 20():456-9. PubMed ID: 4989253
    [No Abstract]   [Full Text] [Related]  

  • 25. [The effectiveness of treating patients with coronary insufficiency with verapamil].
    Kipsidze NN; Capidze GJ
    Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1284+. PubMed ID: 5536553
    [No Abstract]   [Full Text] [Related]  

  • 26. [Behavior of the microcirculation in the experimental treatment of coronary insufficiency with verapamil and the clinical use of verapamil in revascularization of the heart].
    Svecov IM; Derzavez LC; Krutik IG; Culkova IP; Dobrochotov GS
    Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1328+. PubMed ID: 5536557
    [No Abstract]   [Full Text] [Related]  

  • 27. [Nicotinic acid in the treatment of chronic circulatory failure in patients with ischemic heart disease].
    Kats GL; Zhivotovskaia IA; Gnilitskaia VB; Alifanova RE; Mal'tseva NV
    Vrach Delo; 1989 Sep; (9):16-9. PubMed ID: 2609611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of neuroleptanalgesia agents on the collateral coronary circulation and systemic hemodynamics in acute myocardial ischemia].
    Iakushev MP; Sapozhkov AV
    Farmakol Toksikol; 1984; 47(4):59-62. PubMed ID: 6479313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of peripheral vasodilator agents in chronic cardiac insufficiency].
    Zhukova AA; Eliseev OM
    Vopr Revm; 1982; (1):48-55. PubMed ID: 7046243
    [No Abstract]   [Full Text] [Related]  

  • 30. [Intervention in ischemic heart disease and myocardial infarction. 3. Medical intervention].
    Pedersen A
    Ugeskr Laeger; 1982 Jul; 144(29):2156-64. PubMed ID: 6128809
    [No Abstract]   [Full Text] [Related]  

  • 31. The influence of coronary vasodilators on cornary blood flow in man.
    Hilger HH
    Brux Med; 1970 Sep; 50(9):557-65. PubMed ID: 5510355
    [No Abstract]   [Full Text] [Related]  

  • 32. [Commentary on the article of L.G. Betancourt: "Epontol and coronary circulation"].
    Dudziak R
    Anaesthesist; 1970 Jan; 19(1):51-2. PubMed ID: 5440159
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of cardiac glycosides of strophanthin series during experimental disorders of the coronary circulation].
    Azizova SS
    Farmakol Toksikol; 1968; 31(4):421-4. PubMed ID: 5698130
    [No Abstract]   [Full Text] [Related]  

  • 34. [The effect of hyperbaric oxygenation on central hemodynamics, blood gas composition and acid-base status in elderly patients with ischemic heart disease and circulatory insufficiency].
    Khaĭdarova GKh
    Anesteziol Reanimatol; 1990; (6):45-8. PubMed ID: 2075932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Results of complex treatment of patients with chronic circulatory insufficiency using strophanthin, ATP, vitamin B 12, folic acid, calcium pantothenate and unithiol].
    Klykov NV
    Kardiologiia; 1972 Jan; 12(1):126-31. PubMed ID: 5016700
    [No Abstract]   [Full Text] [Related]  

  • 36. [Physio-pharmacology of coronary insufficiency. I].
    Campese VM; Marino A
    Clin Ter; 1974 Mar; 69(4):301-20. PubMed ID: 4152441
    [No Abstract]   [Full Text] [Related]  

  • 37. Pathophysiological basis of the treatment of ischemic heart disease.
    Condorelli M
    Ann Ital Med Int; 1990; 5(3 Pt 3):322-4. PubMed ID: 2081092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hemodynamic disorders and means of their pharmacological correction in cerebral infarction in patients with ischemic heart disease].
    Vinichuk SM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(11):1658-63. PubMed ID: 3434066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Characteristics of the action of strophanthin on central hemodynamics, pulmonary and intrahepatic blood circulation and myocardial contraction].
    Zavolovskaia LI
    Ter Arkh; 1985; 57(3):115-7. PubMed ID: 4002150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Peripheral vasodilators in the treatment of chronic cardiac insufficiency].
    Ol'binskaia LI; Morozova TE
    Klin Med (Mosk); 1987 May; 65(5):20-6. PubMed ID: 2886694
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.